norelgestromin has been researched along with norgestimate in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 10 (76.92) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flor, S; Hahn, DW; Kafrissen, ME; McGuire, JL; Phillips, A; Tolman, EL | 1 |
| Fritzemeier, KH; Hegele-Hartung, C; Krattenmacher, R; Kuhnz, W | 1 |
| Duda, M; Edom, RW; Huang, M; Juzwin, S; Tegegne, G; Tischio, JP; Wong, FA | 1 |
| Abrams, LS; Lasseter, KC; Natarajan, J; Skee, DM; Wong, FA | 1 |
| Zieman, M | 1 |
| Abrams, LS; Natarajan, J; Skee, D; Wong, FA | 1 |
| Abrams, LS; Allen, JG; Creasy, GW; Hammond, GL; Natarajan, J; Siiteri, PK | 1 |
| Lelle, I; Prifti, S; Rabe, T; Strowitzki, T; Zhong, G | 1 |
| Lelle, I; Prifti, S; Rabe, T; Strowitzki, T | 1 |
| Jain, JK; Stanczyk, FZ; White, T | 1 |
| Devineni, D; Janssens, L; LaGuardia, KD; Leung, AT; Massarella, J; Skee, D; Vaccaro, N | 1 |
| Bacquet, A; Balaguer, P; Paris, F; Rabeolina, F; Sultan, C | 1 |
| Badger, GJ; Cushman, M; Johnson, JV; Lowell, J; Rosing, J; Tchaikovski, S | 1 |
2 review(s) available for norelgestromin and norgestimate
| Article | Year |
|---|---|
Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolites.
Topics: Animals; Biotransformation; Contraceptives, Oral; Drug Combinations; Female; Humans; Levonorgestrel; Molecular Structure; Norgestrel; Oximes | 1990 |
Pharmacokinetic overview of Ortho Evra/Evra.
Topics: Administration, Cutaneous; Area Under Curve; Biological Availability; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Half-Life; Humans; Norgestrel; Oximes | 2002 |
5 trial(s) available for norelgestromin and norgestimate
| Article | Year |
|---|---|
Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Contraceptive Agents, Female; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Oximes; Time Factors | 2001 |
Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 2003 |
Effect of oral versus transdermal steroidal contraceptives on androgenic markers.
Topics: Administration, Cutaneous; Adolescent; Adult; Androgens; Androstenedione; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2005 |
Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
Topics: Abdomen; Administration, Cutaneous; Adolescent; Adult; Area Under Curve; Buttocks; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Female; Half-Life; Humans; Middle Aged; Norgestrel; Oximes | 2007 |
Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Antithrombins; Blood Coagulation; Blood Proteins; C-Reactive Protein; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Factor VIII; Female; Fibrinogen; Humans; Norgestrel; Oximes; Protein S; Risk Factors; Thrombosis; von Willebrand Factor | 2008 |
6 other study(ies) available for norelgestromin and norgestimate
| Article | Year |
|---|---|
Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor.
Topics: Animals; Drug Combinations; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Pregnancy; Pregnancy Maintenance; Progesterone; Rabbits; Rats; Rats, Wistar; Receptors, Progesterone | 1995 |
Determination of norgestimate and its metabolites in human serum using high-performance liquid chromatography with tandem mass spectrometric detection.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Stability; Female; Humans; Levonorgestrel; Mass Spectrometry; Molecular Structure; Norgestrel; Oximes; Quality Control; Reproducibility of Results; Sensitivity and Specificity | 1999 |
The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra).
Topics: Administration, Cutaneous; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Progestins | 2002 |
Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression is not regulated by norgestimate or norelgestromin.
Topics: 17-alpha-Hydroxyprogesterone; Cell Line, Tumor; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Ethisterone; Female; Humans; Matrix Metalloproteinase 2; Norgestrel; Oximes; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2004 |
Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells.
Topics: 17-alpha-Hydroxyprogesterone; Breast Neoplasms; Contraceptives, Oral, Combined; Dihydrotestosterone; Drug Combinations; Ethisterone; Genetic Vectors; Humans; Luciferases; Norgestrel; Oximes; Receptors, Androgen; Testosterone; Transfection; Tumor Cells, Cultured | 2004 |
Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Animals; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Humans; Levonorgestrel; Norgestrel; Oximes; Protein Binding; Receptors, Androgen; Time Factors; Transfection | 2007 |